Ledger.Open graph →
SEC Form D · filed October 7, 2020

Talaris Therapeutics, Inc

Offering
$115.0M
Sold
$115.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOUISVILLE, KY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Sandip Agarwala · Louisville, KYDirectorScott Requadt · Cambridge, MAExec · DirectorNick Galakatos · Louisville, KYDirectorGeoff Mackay · Brookline, MADirectorFrancois Nader · Louisville, KYDirectorMark Mcdade · San Francisco, CADirectorSuzanne Ildstad · Louisville, KYExec · DirectorSandip Agarwala · Louisville, KYDirectorScott Requadt · Monmouth Junction, NJExec · DirectorGeoff Mackay · Brookline, MADirectorFrancois Nader · Louisville, KYDirectorMark Mcdade · Boston, MADirectorNick Galakatos · Cambridge, MADirectorSuzanne Ildstad · Louisville, KYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗